STOCK TITAN

The Chemours Company Announces Upsizing and Pricing of Private Offering of $700,000,000 of 7.875% Senior Notes Due 2034

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Negative)
Tags
private placement offering

Chemours (NYSE: CC) priced an upsized private offering of $700,000,000 aggregate principal amount of 7.875% senior notes due March 15, 2034, up from a previously announced $600,000,000.

Interest will be paid semi‑annually starting September 15, 2026; closing is expected March 12, 2026. Net proceeds are intended to fund redemptions of the company's 5.375% senior notes due 2027 and a partial redemption of its 5.750% senior notes due 2028.

Loading...
Loading translation...

Positive

  • Capital raise of $700 million to address near‑term debt
  • Proceeds earmarked to redeem 5.375% (2027) and partially redeem 5.750% (2028) notes
  • Offering expected to close on March 12, 2026, providing quick execution certainty

Negative

  • New coupon of 7.875% increases interest cost versus redeemed 5.375% and 5.750% notes
  • Offering limited to qualified institutional buyers and Regulation S, restricting broad investor access

Key Figures

New notes amount: $700,000,000 Coupon rate: 7.875% Previous offering size: $600,000,000 +5 more
8 metrics
New notes amount $700,000,000 Aggregate principal amount of 7.875% senior notes due 2034
Coupon rate 7.875% Interest rate on senior notes due 2034
Previous offering size $600,000,000 Originally announced aggregate principal before upsizing
Maturity date March 15, 2034 Scheduled maturity of new senior notes
Interest payments Semi-annually Payable March 15 and September 15 each year from Sept 15, 2026
Redemption target notes 5.375% due 2027 Outstanding senior notes to be redeemed with proceeds
Partial redemption notes 5.750% due 2028 Outstanding senior notes targeted for partial redemption
Expected close date March 12, 2026 Expected closing of the private offering, subject to conditions

Market Reality Check

Price: $18.02 Vol: Volume 2,976,788 is at 0....
normal vol
$18.02 Last Close
Volume Volume 2,976,788 is at 0.74x the 20-day average of 4,031,151 shares, indicating below-normal activity pre-announcement. normal
Technical Shares at $17.32 were trading above the 200-day MA of $13.74 but about 20.73% below the 52-week high of $21.85.

Peers on Argus

Sector peers showed mixed moves: ASH -0.18%, KWR -1.3%, IOSP -1.15%, MTX +0.74%,...

Sector peers showed mixed moves: ASH -0.18%, KWR -1.3%, IOSP -1.15%, MTX +0.74%, NGVT +7.01%. With no peers in the momentum scanner and dispersed directions, trading around this Chemours debt offering appeared stock-specific rather than part of a broad specialty chemicals move.

Previous Private placement,offering Reports

3 past events · Latest: Nov 27 (Neutral)
Same Type Pattern 3 events
Date Event Sentiment Move Catalyst
Nov 27 Debt offering completion Neutral -0.4% Completed $600M 8.000% notes due 2033 to redeem euro notes.
Nov 13 Debt offering pricing Neutral +0.8% Priced $600M 8.000% notes due 2033 at 8.000% interest.
Nov 13 Debt offering announcement Neutral -0.7% Announced plan to offer $600M senior notes due 2033.
Pattern Detected

Similar private offerings over the past year saw limited price impact, with an average move of about -0.09% around such announcements.

Recent Company History

Over recent private placement and offering events, Chemours repeatedly used senior unsecured notes to refinance existing debt. In November 2024, it announced and priced $600 million of 8.000% senior notes due 2033, followed by completion of that offering to redeem euro‑denominated 4.000% notes due 2026 and for general corporate purposes. Price reactions to these financing steps stayed modest (from -0.73% to +0.84%), suggesting markets treated them as routine balance sheet management.

Historical Comparison

-0.1% avg move · In the last 12 months, Chemours issued 3 similar private offerings. Average next‑day move was about ...
private placement,offering
-0.1%
Average Historical Move private placement,offering

In the last 12 months, Chemours issued 3 similar private offerings. Average next‑day move was about -0.09%, indicating historically muted equity reactions to such debt financings.

Chemours has consistently used senior unsecured note offerings, first for 2033 maturities refinancing euro 2026 notes and now for 2034 notes aimed at redeeming 2027 and 2028 senior notes, showing an ongoing debt maturity reprofiling pattern.

Market Pulse Summary

This announcement outlines a private offering of $700,000,000 in 7.875% senior notes due 2034, upsiz...
Analysis

This announcement outlines a private offering of $700,000,000 in 7.875% senior notes due 2034, upsized from $600,000,000. Chemours plans to use proceeds to redeem 5.375% notes due 2027 and partially redeem 5.750% notes due 2028, continuing its pattern of managing debt maturities via senior unsecured notes. Key items to watch include closing on March 12, 2026, execution of the planned redemptions, and any follow‑on updates in future filings or earnings calls.

Key Terms

senior notes, qualified institutional buyers, rule 144a, regulation s, +2 more
6 terms
senior notes financial
"private offering of $700,000,000 aggregate principal amount of new 7.875% senior notes due 2034"
Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.
qualified institutional buyers financial
"offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A"
Qualified institutional buyers are large organizations, like big investment firms or banks, that are allowed to buy certain types of investment opportunities not available to everyday investors. Their size and experience matter because it ensures they understand and can handle complex financial deals, making markets more efficient and secure.
rule 144a regulatory
"buyers in reliance on Rule 144A under the Securities Act of 1933, as amended"
Rule 144A is a regulation that makes it easier for companies to sell private bonds to large investors without going through all the usual rules that apply to public sales. It matters because it helps companies raise money more quickly and privately, often attracting big investors looking for special deals.
regulation s regulatory
"outside the United States to non-U.S. persons in compliance with Regulation S under the Securities Act"
Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.
securities act regulatory
"Rule 144A under the Securities Act of 1933, as amended (the "Securities Act")"
A securities act is a law that governs the offering, sale and disclosure of stocks, bonds and other investment products to the public. It requires companies to provide clear, truthful information—like a product label for an investment—so buyers can understand risks and value before they invest. For investors, these rules reduce fraud, promote transparency, and help ensure fair access to market information.
senior unsecured obligations financial
"The Notes will be senior unsecured obligations of Chemours and will be guaranteed"
Senior unsecured obligations are loans or bonds that a company promises to pay back with its own money, but without any special guarantees or collateral. If the company runs into financial trouble, these debts are paid after other debts with priority, meaning they are less protected but still important. They matter because they show how risky it is to lend money to a company.

AI-generated analysis. Not financial advice.

WILMINGTON, Del., Feb. 26, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC) today announced the pricing of its previously announced private offering of $700,000,000 aggregate principal amount of new 7.875% senior notes due 2034 (the "Notes"). The offering size was increased from the previously announced offering size of $600,000,000 aggregate principal amount of Notes. The Notes will bear interest at 7.875% per annum and mature on March 15, 2034. Interest on the Notes will be payable semi-annually on March 15 and September 15 of each year, beginning on September 15, 2026. The Notes will be senior unsecured obligations of Chemours and will be guaranteed by certain of its subsidiaries. The offering is expected to close on March 12, 2026, subject to customary closing conditions.

Chemours intends to use the net proceeds from the offering to fund the redemption of its outstanding 5.375% senior notes due 2027 and the partial redemption of its outstanding 5.750% senior notes due 2028.

The Notes and related guarantees were offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), or outside the United States to non-U.S. persons in compliance with Regulation S under the Securities Act. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the Notes and related guarantees.

The Notes and related guarantees have not been registered under the Securities Act, or the securities laws of any other jurisdiction, and may not be offered or sold in the United States without registration or an applicable exemption from registration requirements.

About The Chemours Company

The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers' biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 5,700 employees and 28 manufacturing sites and serves approximately 2,400 customers in approximately 110 countries.

Forward-Looking Statements

This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the closing of the offering of Notes and Chemours' intended use of the net proceeds therefrom, which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the ability of Chemours to satisfy the conditions to closing the offering and general market conditions which may impact the closing of the offering. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. Matters outside Chemours' control, including general economic conditions, geopolitical conditions, changes in laws and regulations in the United States or other jurisdictions in which we operate, and global health events and weather events, have affected or may affect Chemours' business and operations and may or may continue to hinder Chemours' ability to provide goods and services to customers, cause disruptions in Chemours' supply chains such as through strikes, labor disruptions or other events, adversely affect Chemours'  business partners, significantly reduce the demand for Chemours' products, adversely affect the health and welfare of Chemours' personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include whether the offering of Notes is completed and other risks, uncertainties and other factors discussed in Chemours' filings with the U.S. Securities and Exchange Commission, including in Chemours' Annual Report on Form 10-K for the year ended December 31, 2025. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

CONTACTS:

INVESTORS
Brandon Ontjes
Vice President, Investor Relations
+1.302.773.3309
investor@chemours.com

NEWS MEDIA
Cassie Olszewski
Media Relations & Reputation Leader
+1.302.219.7140
media@chemours.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/the-chemours-company-announces-upsizing-and-pricing-of-private-offering-of-700-000-000-of-7-875-senior-notes-due-2034--302699031.html

SOURCE The Chemours Company

FAQ

What did Chemours (CC) announce about the $700 million senior notes due 2034?

Chemours priced an upsized private offering of $700 million of 7.875% senior notes due March 15, 2034. According to the company, the offering was increased from $600 million and is expected to close on March 12, 2026.

How will Chemours (CC) use proceeds from the 7.875% notes offering?

Chemours intends to use net proceeds to redeem its outstanding 5.375% notes due 2027 and partially redeem 5.750% notes due 2028. According to the company, this is the stated allocation of proceeds from the offering.

When does interest on Chemours (CC) 7.875% notes begin and how is it paid?

Interest on the notes is payable semi‑annually, beginning September 15, 2026, and thereafter each March 15 and September 15. According to the company, the coupon is fixed at 7.875% per annum until maturity on March 15, 2034.

Who can buy Chemours (CC) 7.875% senior notes offered privately?

The notes were offered only to qualified institutional buyers under Rule 144A and to non‑U.S. persons under Regulation S. According to the company, the offering is not registered under the Securities Act and is limited to those eligible investors.

Are the Chemours (CC) 7.875% notes secured or guaranteed by subsidiaries?

The notes are senior unsecured obligations of Chemours and are guaranteed by certain subsidiaries. According to the company, the guarantees are limited to specified subsidiaries and the notes remain unsecured senior debt of the issuer.
Chemours Co

NYSE:CC

CC Rankings

CC Latest News

CC Latest SEC Filings

CC Stock Data

2.76B
149.12M
Specialty Chemicals
Chemicals & Allied Products
Link
United States
WILMINGTON